Navarrabiomed is a public biomedical research center created by the Government of Navarre’s Ministry of Health in 2012. Its mission is to promote, facilitate and perform leading-edge biomedical research to develop and implement innovative therapies that improve the quality of public healthcare.
The center is currently organized into 19 research units and 8 technical and scientific services to promote scientific research and technological development: Biobank, Clinical Trials, Methodology - Health Services Research, Proteomics, Innovation, Animal Lab and Experimental Operating Theater, CellMa Clean Room for Advanced Therapies, and Biocomputing and Data Science. Additionally, Navarrabiomed supports the research activities of multiple associated research groups from the Navarra public health system.
FMS is a leading biomedical research centre with advanced labs, patient access and strong EU project experience for high‑impact health proposals.
Consortium/Coordinator seeks Partners
Partner seeks Consortium/Coordinator
Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change
Destination 3: HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
Destination 6: HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Destination 3: HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
Author
Project manager _ Pre-award at Fundación Pública Miguel Servet - Navarrabiomed
Navarrabiomed’s Protein Crystallography and Structural Immunology Unit provides expertise in structural biology and protein engineering to support the development and optimisation of small-molecule antivirals against pathogens with epidemic potential.
Partner seeks Consortium/Coordinator
Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Author
Project manager _ Pre-award at Fundación Pública Miguel Servet - Navarrabiomed
The Protein Crystallography and Structural Immunology Unit at Navarrabiomed (Spain) is interested in participating in European consortia developing monoclonal antibody-based therapies against emerging and re-emerging flaviviral infections.
Partner seeks Consortium/Coordinator
Destination 3: HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
Author
Project manager _ Pre-award at Fundación Pública Miguel Servet - Navarrabiomed
Navarrabiomed’s Protein Crystallography and Structural Immunology Unit provides complementary expertise for developing monoclonal antibody therapeutics against emerging viral pathogens with epidemic or pandemic potential.
Partner seeks Consortium/Coordinator
Destination 3: HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
Author
Project manager _ Pre-award at Fundación Pública Miguel Servet - Navarrabiomed
The Protein Crystallography and Structural Immunology Unit at Navarrabiomed (Spain) is interested in contributing to multidisciplinary projects developing innovative therapeutic approaches against antimicrobial-resistant bacterial and fungal pathogens.
Partner seeks Consortium/Coordinator
Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
Author
Project manager _ Pre-award at Fundación Pública Miguel Servet - Navarrabiomed
Proteomics, structural biology and protein engineering expertise to support CFPS platform development, protein quality assessment, molecular design, candidate validation and process optimisation for biological production.
Partner seeks Consortium/Coordinator
Destination 6: HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
Author
Project manager _ Pre-award at Fundación Pública Miguel Servet - Navarrabiomed